Ushering in a New Era of Medical Decision-Making
Policy-makers, physicians, and others have struggled to better understand the consequences of medical treatment options on both the cost and quality of health care. The Archimedes model helps health professionals, policy-makers, pharmaceutical companies, and researchers design simulated clinical trials to better understand the implications of care decisions to both advance treatments for such things as heart disease and strokes, and curb unnecessary health care spending. One analysis using this model triggered a new treatment that led to a more than 60 percent reduction in heart attacks and strokes among Kaiser Permanente members.
To give public policy-makers and nonprofits access to this high-powered mathematical modeling tool, RWJF’s Pioneer Portfolio funded the development of the Archimedes Healthcare Simulator (ARCHeS) in 2007 to usher in a new era of medical decision-making. ARCHeS is a web-based interface tool that can provide quick analyses of health policy questions and comparisons of different treatment scenarios and outcomes. The U.S. Department of Health and Human Services (HHS) recently contracted with Archimedes for access to ARCHeS to permit agencies across the department to analyze health spending, treatment, and effectiveness. Other organizations and agencies at the federal and state level, as well as private health plans, are beginning to follow suit, signaling a major step toward using mathematical modeling to transform health and health care for all Americans.
View grant details
Archimedes is partnering with the National Committee for Quality Assurance (NCQA) to develop a new measurement tool that focuses on improving the health outcomes of patients with heart disease and diabetes. NCQA will evaluate The Global Cardiovascular Risk (GCVR) score under a grant from RWJF.
Learn more about the project